For patients with a low CD8 + mTILs/FoxP3 + TILs ratio (n = 50), the differences in OS and BCSS did not reach statistical significance (80% vs. 44%, HR 0.36, 95% CI 0.13–1.02, p = 0.053 and 80% vs. 60%, HR 0.51, 95% CI 0.17–1.52, p = 0.227, respectively) (Fig. 4 c–d).
← all excerpts
The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.
1
0.0530
0.0530